About Us Services Careers FAQ Contact Us 0
Home Speciality Chemicals Pemphigus Vulgaris Market Size, Demand & Share | Forecast-2031 |

Pemphigus Vulgaris Market

Pemphigus Vulgaris Market Size, Share & Trends Analysis Report By Treatment (Corticosteroids, Immunosuppressants, Biological Therapies, Intravenous Immunoglobulin (IVIG) Therapy, Others), By Route of Administration (Intravenous, Subcutaneous, Oral), By End-User (Hospitals and Clinics, Specialty Dermatology Clinics, Research and Academic Laboratories, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRSC54042DR
Study Period 2020-2032 CAGR 8.2%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 470.43 million
Forecast Year 2032 Forecast Year Market Size USD 956.18 million
Largest Market Americas Fastest Growing Market Europe
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Pemphigus Vulgaris Market, By Treatment (2024-2032)
    1. Corticosteroids
    2. Immunosuppressants
    3. Biological Therapies
    4. Intravenous Immunoglobulin (IVIG) Therapy
    5. Others
  2. Pemphigus Vulgaris Market, By Route of Administration (2024-2032)
    1. Intravenous
    2. Subcutaneous
    3. Oral
  3. Pemphigus Vulgaris Market, By End-User (2024-2032)
    1. Hospitals and Clinics
    2. Specialty Dermatology Clinics
    3. Research and Academic Laboratories
    4. Others
    1. North America
      1. North America Pemphigus Vulgaris Market, By Treatment
        1. Corticosteroids
          1. Immunosuppressants
            1. Biological Therapies
              1. Intravenous Immunoglobulin (IVIG) Therapy
                1. Others
                2. North America Pemphigus Vulgaris Market, By Route of Administration
                  1. Intravenous
                    1. Subcutaneous
                      1. Oral
                      2. North America Pemphigus Vulgaris Market, By End-User
                        1. Hospitals and Clinics
                          1. Specialty Dermatology Clinics
                            1. Research and Academic Laboratories
                              1. Others
                              2. U.S.
                                1. U.S. Pemphigus Vulgaris Market, By Treatment
                                  1. Corticosteroids
                                    1. Immunosuppressants
                                      1. Biological Therapies
                                        1. Intravenous Immunoglobulin (IVIG) Therapy
                                          1. Others
                                          2. U.S. Pemphigus Vulgaris Market, By Route of Administration
                                            1. Intravenous
                                              1. Subcutaneous
                                                1. Oral
                                                2. U.S. Pemphigus Vulgaris Market, By End-User
                                                  1. Hospitals and Clinics
                                                    1. Specialty Dermatology Clinics
                                                      1. Research and Academic Laboratories
                                                        1. Others
                                                      2. Canada
                                                    2. Europe
                                                      1. Europe Pemphigus Vulgaris Market, By Treatment
                                                        1. Corticosteroids
                                                          1. Immunosuppressants
                                                            1. Biological Therapies
                                                              1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                1. Others
                                                                2. Europe Pemphigus Vulgaris Market, By Route of Administration
                                                                  1. Intravenous
                                                                    1. Subcutaneous
                                                                      1. Oral
                                                                      2. Europe Pemphigus Vulgaris Market, By End-User
                                                                        1. Hospitals and Clinics
                                                                          1. Specialty Dermatology Clinics
                                                                            1. Research and Academic Laboratories
                                                                              1. Others
                                                                              2. U.K.
                                                                                1. U.K. Pemphigus Vulgaris Market, By Treatment
                                                                                  1. Corticosteroids
                                                                                    1. Immunosuppressants
                                                                                      1. Biological Therapies
                                                                                        1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                          1. Others
                                                                                          2. U.K. Pemphigus Vulgaris Market, By Route of Administration
                                                                                            1. Intravenous
                                                                                              1. Subcutaneous
                                                                                                1. Oral
                                                                                                2. U.K. Pemphigus Vulgaris Market, By End-User
                                                                                                  1. Hospitals and Clinics
                                                                                                    1. Specialty Dermatology Clinics
                                                                                                      1. Research and Academic Laboratories
                                                                                                        1. Others
                                                                                                      2. Germany
                                                                                                      3. France
                                                                                                      4. Spain
                                                                                                      5. Italy
                                                                                                      6. Russia
                                                                                                      7. Nordic
                                                                                                      8. Benelux
                                                                                                      9. Rest of Europe
                                                                                                    2. APAC
                                                                                                      1. APAC Pemphigus Vulgaris Market, By Treatment
                                                                                                        1. Corticosteroids
                                                                                                          1. Immunosuppressants
                                                                                                            1. Biological Therapies
                                                                                                              1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                1. Others
                                                                                                                2. APAC Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                  1. Intravenous
                                                                                                                    1. Subcutaneous
                                                                                                                      1. Oral
                                                                                                                      2. APAC Pemphigus Vulgaris Market, By End-User
                                                                                                                        1. Hospitals and Clinics
                                                                                                                          1. Specialty Dermatology Clinics
                                                                                                                            1. Research and Academic Laboratories
                                                                                                                              1. Others
                                                                                                                              2. China
                                                                                                                                1. China Pemphigus Vulgaris Market, By Treatment
                                                                                                                                  1. Corticosteroids
                                                                                                                                    1. Immunosuppressants
                                                                                                                                      1. Biological Therapies
                                                                                                                                        1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                                          1. Others
                                                                                                                                          2. China Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                                            1. Intravenous
                                                                                                                                              1. Subcutaneous
                                                                                                                                                1. Oral
                                                                                                                                                2. China Pemphigus Vulgaris Market, By End-User
                                                                                                                                                  1. Hospitals and Clinics
                                                                                                                                                    1. Specialty Dermatology Clinics
                                                                                                                                                      1. Research and Academic Laboratories
                                                                                                                                                        1. Others
                                                                                                                                                      2. Korea
                                                                                                                                                      3. Japan
                                                                                                                                                      4. India
                                                                                                                                                      5. Australia
                                                                                                                                                      6. Taiwan
                                                                                                                                                      7. South East Asia
                                                                                                                                                      8. Rest of Asia-Pacific
                                                                                                                                                    2. Middle East and Africa
                                                                                                                                                      1. Middle East and Africa Pemphigus Vulgaris Market, By Treatment
                                                                                                                                                        1. Corticosteroids
                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                            1. Biological Therapies
                                                                                                                                                              1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                                                                1. Others
                                                                                                                                                                2. Middle East and Africa Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                                                                  1. Intravenous
                                                                                                                                                                    1. Subcutaneous
                                                                                                                                                                      1. Oral
                                                                                                                                                                      2. Middle East and Africa Pemphigus Vulgaris Market, By End-User
                                                                                                                                                                        1. Hospitals and Clinics
                                                                                                                                                                          1. Specialty Dermatology Clinics
                                                                                                                                                                            1. Research and Academic Laboratories
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. UAE
                                                                                                                                                                                1. UAE Pemphigus Vulgaris Market, By Treatment
                                                                                                                                                                                  1. Corticosteroids
                                                                                                                                                                                    1. Immunosuppressants
                                                                                                                                                                                      1. Biological Therapies
                                                                                                                                                                                        1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. UAE Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                                                                                            1. Intravenous
                                                                                                                                                                                              1. Subcutaneous
                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                2. UAE Pemphigus Vulgaris Market, By End-User
                                                                                                                                                                                                  1. Hospitals and Clinics
                                                                                                                                                                                                    1. Specialty Dermatology Clinics
                                                                                                                                                                                                      1. Research and Academic Laboratories
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                      1. LATAM Pemphigus Vulgaris Market, By Treatment
                                                                                                                                                                                                        1. Corticosteroids
                                                                                                                                                                                                          1. Immunosuppressants
                                                                                                                                                                                                            1. Biological Therapies
                                                                                                                                                                                                              1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                2. LATAM Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                                                                                                                  1. Intravenous
                                                                                                                                                                                                                    1. Subcutaneous
                                                                                                                                                                                                                      1. Oral
                                                                                                                                                                                                                      2. LATAM Pemphigus Vulgaris Market, By End-User
                                                                                                                                                                                                                        1. Hospitals and Clinics
                                                                                                                                                                                                                          1. Specialty Dermatology Clinics
                                                                                                                                                                                                                            1. Research and Academic Laboratories
                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                              2. Brazil
                                                                                                                                                                                                                                1. Brazil Pemphigus Vulgaris Market, By Treatment
                                                                                                                                                                                                                                  1. Corticosteroids
                                                                                                                                                                                                                                    1. Immunosuppressants
                                                                                                                                                                                                                                      1. Biological Therapies
                                                                                                                                                                                                                                        1. Intravenous Immunoglobulin (IVIG) Therapy
                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                          2. Brazil Pemphigus Vulgaris Market, By Route of Administration
                                                                                                                                                                                                                                            1. Intravenous
                                                                                                                                                                                                                                              1. Subcutaneous
                                                                                                                                                                                                                                                1. Oral
                                                                                                                                                                                                                                                2. Brazil Pemphigus Vulgaris Market, By End-User
                                                                                                                                                                                                                                                  1. Hospitals and Clinics
                                                                                                                                                                                                                                                    1. Specialty Dermatology Clinics
                                                                                                                                                                                                                                                      1. Research and Academic Laboratories
                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                      2. Mexico
                                                                                                                                                                                                                                                      3. Argentina
                                                                                                                                                                                                                                                      4. Chile
                                                                                                                                                                                                                                                      5. Colombia
                                                                                                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                                                                                                  Related Reports

                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                  The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                  The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                  The global inflight catering market size was valued at USD 12.24 billion in 2022. It is estimated to reach USD 32.13 billion by 2031, growing at a CAGR of 11.32% during the forecast period (2023–2031). The primary catalyst for growth in the inf
                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                  The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                  Buy Now
                                                                                                                                                                                                                                                  Global Report
                                                                                                                                                                                                                                                  The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                  Buy Now

                                                                                                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                                                                                                  We are featured on :

                                                                                                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                                                                                                  © Copyright . All rights Reserved.